BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date they have committed $19.6 million to 29 seed-stage companies and 15 pre-seed investments.